🇺🇸 FDA
Patent

US 6057346

Inhibition of retroviral LTR promoters by calcium response modifiers

expired A61KA61K31/4174A61K31/4192

Quick answer

US patent 6057346 (Inhibition of retroviral LTR promoters by calcium response modifiers) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/4174, A61K31/4192, A61P, A61P31/12